Assenagon Asset Management S.A. boosted its position in shares of HealthStream, Inc. (NASDAQ:HSTM - Free Report) by 37.3% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 201,601 shares of the technology company's stock after acquiring an additional 54,775 shares during the period. Assenagon Asset Management S.A. owned 0.66% of HealthStream worth $5,814,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. GAMMA Investing LLC lifted its position in shares of HealthStream by 172.1% in the second quarter. GAMMA Investing LLC now owns 996 shares of the technology company's stock valued at $28,000 after acquiring an additional 630 shares in the last quarter. Point72 DIFC Ltd bought a new position in HealthStream in the 2nd quarter worth approximately $38,000. Copeland Capital Management LLC purchased a new stake in HealthStream during the 3rd quarter valued at approximately $63,000. CWM LLC raised its position in shares of HealthStream by 405.4% during the second quarter. CWM LLC now owns 2,709 shares of the technology company's stock valued at $76,000 after buying an additional 2,173 shares during the last quarter. Finally, Diversified Trust Co purchased a new position in shares of HealthStream in the first quarter worth $213,000. Institutional investors own 69.58% of the company's stock.
Insider Buying and Selling at HealthStream
In other news, SVP Kevin P. O'hara sold 3,000 shares of the firm's stock in a transaction dated Wednesday, August 7th. The shares were sold at an average price of $28.03, for a total value of $84,090.00. Following the completion of the sale, the senior vice president now owns 9,527 shares in the company, valued at approximately $267,041.81. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other HealthStream news, Director Tate Deborah Taylor sold 1,400 shares of the company's stock in a transaction on Thursday, August 29th. The stock was sold at an average price of $28.53, for a total value of $39,942.00. Following the transaction, the director now owns 22,326 shares of the company's stock, valued at $636,960.78. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, SVP Kevin P. O'hara sold 3,000 shares of HealthStream stock in a transaction on Wednesday, August 7th. The stock was sold at an average price of $28.03, for a total value of $84,090.00. Following the sale, the senior vice president now owns 9,527 shares of the company's stock, valued at approximately $267,041.81. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 20.60% of the company's stock.
Analyst Ratings Changes
Several equities analysts recently weighed in on HSTM shares. Canaccord Genuity Group raised their target price on shares of HealthStream from $28.00 to $29.00 and gave the company a "hold" rating in a research note on Wednesday, October 23rd. Barclays raised their price objective on HealthStream from $32.00 to $34.00 and gave the company an "overweight" rating in a research report on Wednesday, October 23rd. StockNews.com downgraded HealthStream from a "strong-buy" rating to a "buy" rating in a research report on Wednesday, July 24th. Finally, Craig Hallum raised HealthStream to a "strong-buy" rating in a research note on Thursday, October 17th. Two investment analysts have rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, HealthStream presently has an average rating of "Moderate Buy" and a consensus price target of $31.50.
Read Our Latest Analysis on HSTM
HealthStream Price Performance
Shares of HealthStream stock traded down $0.10 during trading hours on Wednesday, reaching $29.23. The company's stock had a trading volume of 72,820 shares, compared to its average volume of 113,466. The firm has a 50 day moving average price of $28.74 and a 200-day moving average price of $28.01. The stock has a market cap of $888.53 million, a P/E ratio of 50.40, a P/E/G ratio of 4.45 and a beta of 0.36. HealthStream, Inc. has a one year low of $23.92 and a one year high of $31.15.
HealthStream (NASDAQ:HSTM - Get Free Report) last issued its quarterly earnings data on Monday, October 21st. The technology company reported $0.19 earnings per share for the quarter, topping the consensus estimate of $0.13 by $0.06. The company had revenue of $73.10 million for the quarter, compared to analysts' expectations of $73.53 million. HealthStream had a return on equity of 5.67% and a net margin of 6.84%. The firm's revenue for the quarter was up 4.0% on a year-over-year basis. During the same period in the previous year, the firm posted $0.13 earnings per share. As a group, sell-side analysts forecast that HealthStream, Inc. will post 0.56 EPS for the current fiscal year.
HealthStream Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Monday, November 4th will be paid a dividend of $0.028 per share. This represents a $0.11 annualized dividend and a yield of 0.38%. The ex-dividend date of this dividend is Monday, November 4th. HealthStream's payout ratio is 18.97%.
HealthStream Company Profile
(
Free Report)
HealthStream, Inc provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States. The company's solutions help healthcare organizations in meeting their ongoing clinical development, talent management, training, education, assessment, competency management, safety and compliance, and scheduling, as well as provider credentialing, privileging, and enrollment needs.
Further Reading
Before you consider HealthStream, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HealthStream wasn't on the list.
While HealthStream currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.